MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Idiopathic Upper Limb Dystonia – Time for a better understanding

    T. Ercoli, R. Pellicciari, G. Fabbrini, G. Ferrazzano, MM. Mascia, R. Eleopra, A. Albanese, R. Erro, P. Barone, L. Avanzino, R. Ceravolo, M. Esposito, L. Bertolasi, C. Scaglione, A.R Bentivoglio, M.C Altavista, F. Bono, P. Girlanda, A. Pisani, M.S Cotelli, B. Minafra, A. Castagna, M. Zibetti, S. Misceo, L. Magistrelli, G. Cossu, M. Coletti Moja, A. Berardelli, G. Defazio (Cagliari, Italy)

    Objective: This cross-sectional study examined the clinical and demographic features of idiopathic adult-onset upper limb dystonia (ULD) related to onset site, spread, and task-specificity in…
  • MDS Virtual Congress 2020

    The Dystonia Coalition Natural History Project: An Available Research Resource

    S. Norris, H. Jinnah, L. Wright, G. Kilic-Berkmen, J. Hieshetter, D. Peterson, S. Pirio-Richardson, J. Perlmutter (St. Louis, MO, USA)

    Objective: The purpose of this collaborative, international effort is to provide an available resource containing clinical and video data along with biospecimens for dystonia research.…
  • MDS Virtual Congress 2020

    Intact organization of tactile space in isolated focal dystonia

    T. Mainka, E. Azanon Gracia, K. Zeuner, A. Knutzen, T. Bäumer, J. Neumann, A. Kühn, M. Longo, C. Ganos (Berlin, Germany)

    Objective: To assess the organization of tactile space in patients with focal dystonia. Background: Changes in cortical sensorimotor organization have been previously demonstrated in isolated…
  • MDS Virtual Congress 2020

    The Accreditation and Certification of the Movement Disorders Subspecialty: A Five-Year Follow-Up Study

    S. O'Shea, L. Gutmann, L. Faulkner (Boston, MA, USA)

    Objective: The purpose of our study was to assess if sentiments regarding the accreditation and certification of Movement Disorders Fellowships have changed over the past…
  • MDS Virtual Congress 2020

    Predicting the effects of Tumor Necrosis Factor inhibition on the risk and age at onset of Parkinson’s disease: A Mendelian randomization study

    X. Kang, A. Ploner, N. Pedersen, J. Ludvigsson, S. Bandres-Ciga, A. Noyce, K. Wirdefeldt, D. Williams (Stockholm, Sweden)

    Objective: To evaluate whether inhibition of Tumor Necrosis Factor (TNF) signaling may reduce the risk of Parkinson’s disease (PD) and/or delay onset of PD. Background:…
  • MDS Virtual Congress 2020

    Emerging motor dysfunction in those at-risk of Parkinson’s disease: 5-year follow-up of PREDICT-PD participants

    C. Simonet, A. Schrag, J. Bestwick, A. Lees, A. Noyce (London, United Kingdom)

    Objective: To determine how motor features emerge over time in individuals estimated to be at higher risk of Parkinson’s disease (PD), compared with lower risk…
  • MDS Virtual Congress 2020

    A novel POLG2 variant leads to disrupted mitochondrial integrity in a family with cerebellar ataxia and progressive ophthalmoplegia

    K. Lohmann, M. Borsche, H. Baumann, S. Tunc, E. Knappe, S. Özcakir, J. Trinh, M. Dulovic-Mahlow, N. Brüggemann (Luebeck, Germany)

    Objective: To investigate the molecular consequences of a variant of unknown significance (VUS) in POLG2. Background: Mitochondrial DNA (mtDNA) is replicated by DNA polymerase gamma,…
  • MDS Virtual Congress 2020

    Huntington’s disease in Egypt; A big challenge for a mysterious disease

    S. El-Jaafary, A. Sabbah, H. Amer (Cairo, Egypt)

    Objective: To identify the challenges of managing Huntington’s disease in Egypt in order to overcome them. Background: Huntington’s disease (HD) is considered a rare disease…
  • MDS Virtual Congress 2020

    Healthcare Utilization and Cost Burden at the End-of-Life Among Medicare Beneficiaries with Huntington’s Disease

    S. Reddy, A. Exuzides, E. Chang, C. Paydar, G. Yohrling (Beverly Hills, CA, USA)

    Objective: To examine healthcare utilization (HCU) and costs occurring at the end of life among deceased Medicare beneficiaries who were diagnosed with Huntington’s disease (HD).…
  • MDS Virtual Congress 2020

    Myoclonic epilepsy with ragged-red fibers: the first described clinical case in Ukraine

    Y. Trufanov, N. Svyrydova, A. Galusha, V. Sereda, V. Svistun, I. Zarashchak, A. Yanchak (Kyiv, Ukraine)

    Objective: To provide a description of a case of myoclonic epilepsy with ragged-red fibers (MERRF) diagnosed in Kyiv, Ukraine. Background: MERRF is a rare mitochondrial…
  • « Previous Page
  • 1
  • …
  • 122
  • 123
  • 124
  • 125
  • 126
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley